Cooper Cos Stock News

The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care

SAN FRANCISCO, Sept. 23, 2026 /PRNewswire/ -- Investors in The Cooper Companies, Inc. (NASDAQ: COO) saw the price of their shares trade down $9.31 (-14.6%) after the company reported Q3 2026 financial results that included revelations of its U.S. channel inventory destocking along with other negative surprises.

Activist investor Jana Partners on Friday urged Cooper Companies to launch an external search for a new CEO and consider ​asset sales, arguing recent missteps have hurt investor ‌confidence and weighed on the medical device maker's market value.

Cooper Cos. stock rises as activist investor Jana Partners calls for the company to search for a new CEO and sell a key business segment.

Calls for Board to Commence Immediate External CEO Search, Appoint New Board Chair and ExploreAsset Sales NEW YORK, Sept. 18, 2026 /PRNewswire/ -- JANA Partners ("JANA") today announced that it has sent a letter to the Board of Directors (the "Board") of The Cooper Companies, Inc. (Nasdaq: COO) ("Cooper" or the "Company") highlighting the companies consistent underperformance and calling on it ...

The medical-device manufacturer requires an urgent overhaul to address its “chronic underperformance,” the activist hedge fund's letter says.

SAN FRANCISCO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- On September 10, 2026, investors in The Cooper Companies, Inc. (NASDAQ: COO) saw the price of their shares trade down $9.31 (-14.6%) after the company reported Q3 2026 financial results that included revelations of its U.S. channel inventory destocking along with other negative surprises.

The medical devices maker took a 5% hit on its stock before two big pieces of news—a guidance cut and the decision not to sell its women's health business.